Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats

Muzamil Ahmad, Sofiyan Saleem, Abdullah Shafique Ahmad, Mubeen Ahmad Ansari, Seema Yousuf, MD Nasrul Hoda, Fakhrul Islam

Research output: Contribution to journalArticle

136 Citations (Scopus)

Abstract

6-Hydroxydopamine (6-OHDA) is one of the most widely used rat models for Parkinson's disease. There is ample evidence in the literature that 6-OHDA elicits its toxic manifestations through oxidant stress. In the present study, we evaluated the anti-parkinsonian effects of Withania somnifera extract, which has been reported to have potent anti-oxidant, anti-peroxidative and free radical quenching properties in various diseased conditions. Rats were pretreated with 100, 200 and 300 mg/kg b.w. of the W. somnifera extract orally for 3 weeks. On day 21, 2 μL of 6-OHDA (10 μg in 0.1% in ascorbic acid-saline) was infused into the right striatum while sham operated group received 2 μL of the vehicle. Three weeks after 6-OHDA injections, rats were tested for neurobehavioral activity and were killed 5 weeks after lesioning for the estimation of lipidperoxidation, reduced glutathione content, activities of glutathione-S-transferase, glutathione reductase, glutathione peroxidase, superoxide dismutase and catalase, catecholamine content, dopaminergic D 2 receptor binding and tyrosine hydroxylase expression. W. somnifera extract was found to reverse all the parameters significantly in a dose-dependent manner. Thus, the study demonstrates that the extract of W. somnifera may be helpful in protecting the neuronal injury in Parkinson's disease.

Original languageEnglish (US)
Pages (from-to)137-147
Number of pages11
JournalHuman and Experimental Toxicology
Volume24
Issue number3
DOIs
StatePublished - Mar 1 2005

Fingerprint

Withania
Oxidopamine
Parkinsonian Disorders
Neuroprotective Agents
Rats
Oxidants
Parkinson Disease
Glutathione Reductase
Poisons
Tyrosine 3-Monooxygenase
Glutathione Peroxidase
Glutathione Transferase
Catalase
Ascorbic Acid
Superoxide Dismutase
Free Radicals
Catecholamines
Glutathione
Quenching
Injections

Keywords

  • 6-hydroxydopamine
  • Antioxidant
  • Dopamine
  • Oxidative stress
  • Parkinson's disease
  • Withania somnifera

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Ahmad, M., Saleem, S., Ahmad, A. S., Ansari, M. A., Yousuf, S., Hoda, MD. N., & Islam, F. (2005). Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats. Human and Experimental Toxicology, 24(3), 137-147. https://doi.org/10.1191/0960327105ht509oa

Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats. / Ahmad, Muzamil; Saleem, Sofiyan; Ahmad, Abdullah Shafique; Ansari, Mubeen Ahmad; Yousuf, Seema; Hoda, MD Nasrul; Islam, Fakhrul.

In: Human and Experimental Toxicology, Vol. 24, No. 3, 01.03.2005, p. 137-147.

Research output: Contribution to journalArticle

Ahmad, M, Saleem, S, Ahmad, AS, Ansari, MA, Yousuf, S, Hoda, MDN & Islam, F 2005, 'Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats', Human and Experimental Toxicology, vol. 24, no. 3, pp. 137-147. https://doi.org/10.1191/0960327105ht509oa
Ahmad, Muzamil ; Saleem, Sofiyan ; Ahmad, Abdullah Shafique ; Ansari, Mubeen Ahmad ; Yousuf, Seema ; Hoda, MD Nasrul ; Islam, Fakhrul. / Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats. In: Human and Experimental Toxicology. 2005 ; Vol. 24, No. 3. pp. 137-147.
@article{1e8d2de280ac4349bc631302efd7afd3,
title = "Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats",
abstract = "6-Hydroxydopamine (6-OHDA) is one of the most widely used rat models for Parkinson's disease. There is ample evidence in the literature that 6-OHDA elicits its toxic manifestations through oxidant stress. In the present study, we evaluated the anti-parkinsonian effects of Withania somnifera extract, which has been reported to have potent anti-oxidant, anti-peroxidative and free radical quenching properties in various diseased conditions. Rats were pretreated with 100, 200 and 300 mg/kg b.w. of the W. somnifera extract orally for 3 weeks. On day 21, 2 μL of 6-OHDA (10 μg in 0.1{\%} in ascorbic acid-saline) was infused into the right striatum while sham operated group received 2 μL of the vehicle. Three weeks after 6-OHDA injections, rats were tested for neurobehavioral activity and were killed 5 weeks after lesioning for the estimation of lipidperoxidation, reduced glutathione content, activities of glutathione-S-transferase, glutathione reductase, glutathione peroxidase, superoxide dismutase and catalase, catecholamine content, dopaminergic D 2 receptor binding and tyrosine hydroxylase expression. W. somnifera extract was found to reverse all the parameters significantly in a dose-dependent manner. Thus, the study demonstrates that the extract of W. somnifera may be helpful in protecting the neuronal injury in Parkinson's disease.",
keywords = "6-hydroxydopamine, Antioxidant, Dopamine, Oxidative stress, Parkinson's disease, Withania somnifera",
author = "Muzamil Ahmad and Sofiyan Saleem and Ahmad, {Abdullah Shafique} and Ansari, {Mubeen Ahmad} and Seema Yousuf and Hoda, {MD Nasrul} and Fakhrul Islam",
year = "2005",
month = "3",
day = "1",
doi = "10.1191/0960327105ht509oa",
language = "English (US)",
volume = "24",
pages = "137--147",
journal = "Human and Experimental Toxicology",
issn = "0960-3271",
publisher = "SAGE Publications Inc.",
number = "3",

}

TY - JOUR

T1 - Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats

AU - Ahmad, Muzamil

AU - Saleem, Sofiyan

AU - Ahmad, Abdullah Shafique

AU - Ansari, Mubeen Ahmad

AU - Yousuf, Seema

AU - Hoda, MD Nasrul

AU - Islam, Fakhrul

PY - 2005/3/1

Y1 - 2005/3/1

N2 - 6-Hydroxydopamine (6-OHDA) is one of the most widely used rat models for Parkinson's disease. There is ample evidence in the literature that 6-OHDA elicits its toxic manifestations through oxidant stress. In the present study, we evaluated the anti-parkinsonian effects of Withania somnifera extract, which has been reported to have potent anti-oxidant, anti-peroxidative and free radical quenching properties in various diseased conditions. Rats were pretreated with 100, 200 and 300 mg/kg b.w. of the W. somnifera extract orally for 3 weeks. On day 21, 2 μL of 6-OHDA (10 μg in 0.1% in ascorbic acid-saline) was infused into the right striatum while sham operated group received 2 μL of the vehicle. Three weeks after 6-OHDA injections, rats were tested for neurobehavioral activity and were killed 5 weeks after lesioning for the estimation of lipidperoxidation, reduced glutathione content, activities of glutathione-S-transferase, glutathione reductase, glutathione peroxidase, superoxide dismutase and catalase, catecholamine content, dopaminergic D 2 receptor binding and tyrosine hydroxylase expression. W. somnifera extract was found to reverse all the parameters significantly in a dose-dependent manner. Thus, the study demonstrates that the extract of W. somnifera may be helpful in protecting the neuronal injury in Parkinson's disease.

AB - 6-Hydroxydopamine (6-OHDA) is one of the most widely used rat models for Parkinson's disease. There is ample evidence in the literature that 6-OHDA elicits its toxic manifestations through oxidant stress. In the present study, we evaluated the anti-parkinsonian effects of Withania somnifera extract, which has been reported to have potent anti-oxidant, anti-peroxidative and free radical quenching properties in various diseased conditions. Rats were pretreated with 100, 200 and 300 mg/kg b.w. of the W. somnifera extract orally for 3 weeks. On day 21, 2 μL of 6-OHDA (10 μg in 0.1% in ascorbic acid-saline) was infused into the right striatum while sham operated group received 2 μL of the vehicle. Three weeks after 6-OHDA injections, rats were tested for neurobehavioral activity and were killed 5 weeks after lesioning for the estimation of lipidperoxidation, reduced glutathione content, activities of glutathione-S-transferase, glutathione reductase, glutathione peroxidase, superoxide dismutase and catalase, catecholamine content, dopaminergic D 2 receptor binding and tyrosine hydroxylase expression. W. somnifera extract was found to reverse all the parameters significantly in a dose-dependent manner. Thus, the study demonstrates that the extract of W. somnifera may be helpful in protecting the neuronal injury in Parkinson's disease.

KW - 6-hydroxydopamine

KW - Antioxidant

KW - Dopamine

KW - Oxidative stress

KW - Parkinson's disease

KW - Withania somnifera

UR - http://www.scopus.com/inward/record.url?scp=18044398197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18044398197&partnerID=8YFLogxK

U2 - 10.1191/0960327105ht509oa

DO - 10.1191/0960327105ht509oa

M3 - Article

C2 - 15901053

AN - SCOPUS:18044398197

VL - 24

SP - 137

EP - 147

JO - Human and Experimental Toxicology

JF - Human and Experimental Toxicology

SN - 0960-3271

IS - 3

ER -